These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3691293)

  • 1. Plasma fluorescein decay determination during fluorophotometry.
    Boot JP; Van Best JA; Tjin a Tsoi EW; Kappelhof JP; Oosterhuis JA
    Doc Ophthalmol; 1987 Apr; 65(4):403-22. PubMed ID: 3691293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.
    Van Schaik HJ; Heintz B; Larsen M; Leite E; Rosas V; Schalnus R; Van Best JA
    Graefes Arch Clin Exp Ophthalmol; 1997 Oct; 235(10):639-46. PubMed ID: 9349948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood aqueous barrier permeability versus age by fluorophotometry.
    van Best JA; Kappelhof JP; Laterveer L; Oosterhuis JA
    Curr Eye Res; 1987 Jul; 6(7):855-63. PubMed ID: 3621981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inward permeability of the blood-retinal barrier by fluorophotometry.
    Kappelhof JP; van Best JA; van Valenberg PL; Oosterhuis JA
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):665-71. PubMed ID: 3557870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP; Rusin MM
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):419-22. PubMed ID: 3093315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for determination of corneal epithelial permeability in humans.
    de Kruijf EJ; Boot JP; Laterveer L; van Best JA; Ramselaar JA; Oosterhuis JA
    Curr Eye Res; 1987 Nov; 6(11):1327-34. PubMed ID: 3427981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects.
    Bungay PM; Roy MS; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1321-7. PubMed ID: 2783065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE; Chahal PS; Fallon TJ; Cunningham JR; Neal MJ; Kohner EM
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood retinal and blood aqueous barriers in diabetics by fluorophotometry.
    Boot JP; van Gerven JM; van Best JA; Vrij L; Lemkes HH; Oosterhuis JA
    Doc Ophthalmol; 1989 Jan; 71(1):19-27. PubMed ID: 2743854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion coefficient through the blood-aqueous barrier using a standard protocol.
    van Best J; del Castillo JB; Diestelhorst M; Heintz B; Leite E; Liesenborghs LF; Schalnus R
    Br J Ophthalmol; 1996 Apr; 80(4):356-62. PubMed ID: 8703890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human corneal endothelial permeability to fluorescein and fluorescein glucuronide.
    Seto C; Araie M; Sawa M; Takase M
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1457-63. PubMed ID: 3623832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical measurement of endothelial permeability.
    Carlson KH; Bourne WM
    Cornea; 1988; 7(3):183-9. PubMed ID: 3048882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.